Literature DB >> 24390580

Labelling of end-of-life decisions by physicians.

Jef Deyaert, Kenneth Chambaere, Joachim Cohen, Marc Roelands, Luc Deliens.   

Abstract

OBJECTIVES: Potentially life-shortening medical end-of-life practices (end-of-life decisions (ELDs)) remain subject to conceptual vagueness. This study evaluates how physicians label these practices by examining which of their own practices (described according to the precise act, the intention, the presence of an explicit patient request and the self-estimated degree of life shortening)they label as euthanasia or sedation.
METHODS: We conducted a large stratified random sample of death certificates from 2007 (N=6927).The physicians named on the death certificate were approached by means of a postal questionnaire asking about ELDs made in each case and asked to choose the most appropriate label to describe the ELD. Response rate was 58.4%.
RESULTS: In the vast majority of practices labelled as euthanasia, the self-reported actions of the physicians corresponded with the definition in the Belgian euthanasia legislation; practices labelled as palliative or terminal sedation lack clear correspondence with definitions of sedation as presented in existing guidelines. In these cases, an explicit life-shortening intention by means of drug administration was present in 21.6%, life shortening was estimated at more than 24 h in 51% and an explicit patient request was absentin 79.7%. DISCUSSION: Our results suggest that, unlike euthanasia,the concept of palliative or terminal sedation covers abroad range of practices in the minds of physicians. This ambiguity can be a barrier to appropriate sedation practice and indicates a need for better knowledge of the practice of palliative sedation by physicians.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390580     DOI: 10.1136/medethics-2013-101854

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  8 in total

1.  In-hospital end-of-life decisions after new traumatic spinal cord injury in the Netherlands.

Authors:  R Osterthun; F W A van Asbeck; J H B Nijendijk; M W M Post
Journal:  Spinal Cord       Date:  2016-04-12       Impact factor: 2.772

2.  End-of-Life Decision Making in Palliative Care and Recommendations of the Council of Europe: Qualitative Secondary Analysis of Interviews and Observation Field Notes.

Authors:  Sandra Martins Pereira; Emília Fradique; Pablo Hernández-Marrero
Journal:  J Palliat Med       Date:  2018-01-03       Impact factor: 2.947

3.  Nonconsensual withdrawal of nutrition and hydration in prolonged disorders of consciousness: authoritarianism and trustworthiness in medicine.

Authors:  Mohamed Y Rady; Joseph L Verheijde
Journal:  Philos Ethics Humanit Med       Date:  2014-11-07       Impact factor: 2.464

Review 4.  Response to LiPuma and DeMarco's Article on "Hastening Death".

Authors:  Julia Zenz
Journal:  Health Serv Insights       Date:  2017-06-06

5.  End-of-Life Decision-Making in Pediatric and Neonatal Intensive Care Units in Croatia-A Focus Group Study among Nurses and Physicians.

Authors:  Filip Rubic; Marko Curkovic; Lovorka Brajkovic; Bojana Nevajdic; Milivoj Novak; Boris Filipovic-Grcic; Julije Mestrovic; Kristina Lah Tomulic; Branimir Peter; Ana Borovecki
Journal:  Medicina (Kaunas)       Date:  2022-02-07       Impact factor: 2.430

6.  Medicalisation, suffering and control at the end of life: The interplay of deep continuous palliative sedation and assisted dying.

Authors:  Gitte Hanssen Koksvik; Naomi Richards; Sheri Mila Gerson; Lars Johan Materstvedt; David Clark
Journal:  Health (London)       Date:  2020-12-11

7.  Palliative care professionals' willingness to perform euthanasia or physician assisted suicide.

Authors:  Julia Zenz; Michael Tryba; Michael Zenz
Journal:  BMC Palliat Care       Date:  2015-11-14       Impact factor: 3.234

8.  Trends in Continuous Deep Sedation until Death between 2007 and 2013: A Repeated Nationwide Survey.

Authors:  Lenzo Robijn; Joachim Cohen; Judith Rietjens; Luc Deliens; Kenneth Chambaere
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.